Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Agfa-Gevaert    AGFB   BE0003755692

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

AGFA-GEVAERT : AAMI 2012: Agfa HealthCare delivers portable digital imaging solutions with a focus on image quality and refined workflow

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/29/2012 | 04:55pm CEST
DX-D 100 system with advanced MUSICA2 image processing on display at annual expo
  • Press release
  • Mortsel, Belgium/Greenville, SC
  • May 29, 2012 04:00

- Agfa HealthCare will showcase digital radiography solutions at AAMI to meet a range of needs and budgets without sacrificing efficiency or image quality.
- Portable DX-D 100 system enables point-of-care treatment for patients in need.
- Agfa HealthCare demonstrates commitment to efficiency and cost-savings with immediate image availability and integration.

(AAMI 2012, Booth #420, Charlotte, NC) Agfa HealthCare announces today its showcase of versatile direct radiography (DR) imaging solutions which will be on display in booth #420 at AAMI 2012, the Association for the Advancement of Medical Instrumentation Conference & Expo, June 2-4 in Charlotte, N.C. Focused on the development and delivery of DR systems that meet the high quality standards in medical imaging, Agfa HealthCare offers a full range of digital imaging solutions to meet various budgets, environments and clinical applications requirements.
"Today's imaging centers, hospitals and government facilities demand portable technology that can serve a broad range of radiographic patient needs along with quick, easy image viewing for assessment at the point of care," said Greg Cefalo, U.S. Digital Radiography Business Unit Manager, Agfa HealthCare U.S. "That's exactly what Agfa HealthCare delivers with the powerful combination of the DX-D 100 digital x-ray system, MUSICA2 image processing, and NX workstation-with much needed cost savings, too."



DX-D 100: The heavy duty, fully motorized, portable DR X-ray unit, the DX-D 100, brings imaging to the field, enabling DR quality images to be captured in remote environments, at the patient bedside, or any place where space is limited. Thanks to its ergonomic design, the DX-D 100 is easily moved and operated by a single person, for improved quality and efficiency of bedside imaging. It delivers immediate previews and leading-edge resolution for a broad range of general radiography X-ray studies.

MUSICA2: Inherent to every DR solution is MUSICA2, Agfa HealthCare's gold standard image processing software for excellent image quality, which makes use of the company's established NX platform for a smooth workflow. The exam independent imaging processing software automatically analyzes each image, optimizing processing parameters and generating consistent, top-notch image results. The software can also improve the overall visibility of clinically relevant structures, making especially low contrast details more easily perceptible.

NX Workstation: The smooth workflow of Agfa HealthCare's NX Workstation enables seamless connectivity with PACS, HIS and RIS. When a user selects an exam, the X-ray settings are automatically transferred to the generator and displayed on the touch-screen console. This intuitive quality control tool was designed with radiographers and radiologists in mind, facilitating improved interoperability, convenience and speed for "anytime, anywhere" care delivery.
"For departments needing to 'do more with less,' our focus on workflow provides the efficiency needed to lower exam costs and enable better communication between physicians," said Cefalo. "The government sector, especially, can benefit from the integration elements we've put in place."

Agfa HealthCare's additional offerings in the DR market include the DX-D 300, DX-D 400, DX-D 500n, and DX-D 600 along with Cesium Iodide (CsI) and Gadolinium Oxy-Sulphide (GOS) detectors for every system.

To schedule a demo or speak with a product expert, please contact [email protected] or visit the Agfa HealthCare booth #420.


Miriam Ladin
Marketing Communications Director - North America
One Crosswind Road
RI 02891 Westerly, Rhode Island (USA)
tel:+1 (0)401 604 22 03
fax:+1 (0)401 596 85 62
[email protected]
Geertrui De Smet
Global PR Manager Agfa HealthCare
tel:+32 (0) 3 444 73 06
[email protected]
Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel:+32 (0)3 444 80 15
fax:+32 (0)3 444 50 05
[email protected]
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AGFA-GEVAERT
10/13 AGFA GEVAERT : reports on study aiming at focused growth
10/11 AGFA GEVAERT : rapporteert over studie met het oog op doelgerichte groei
10/11 AGFA GEVAERT : reports on study aiming at focused growth
09/25 EMC : Agfa HealthCare and Federation des Hopitaux Luxembourgeois sign contract f..
09/21 AGFA GEVAERT : HealthCare and Fédération des Hôpitaux Luxembourgeois sign contra..
08/23 AGFA GEVAERT : publishes its second quarter 2017 results regulated information
08/23 AGFA GEVAERT : publishes its second quarter 2017 results – regulated infor..
08/23 AGFA GEVAERT : announces a study aiming at focused growth
08/23 AGFA-GEVAERT : Agfa announces a study aiming at focused growth
08/23 AGFA-GEVAERT PUBLISHES ITS SECOND QU : 45 a.m. CET
More news
News from SeekingAlpha
08/23 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q2 2017 Results - Earnings C..
08/23 Agfa-Gavaert NV reports Q2 results
08/23 Agfa-Gavaert NV 2017 Q2 - Results - Earnings Call Slides
05/09 Agfa-Gavaert NV reports Q1 results
03/08 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q4 2016 Results - Earnings C..
Financials (€)
Sales 2017 2 446 M
EBIT 2017 165 M
Net income 2017 70,0 M
Finance 2017 113 M
Yield 2017 -
P/E ratio 2017 8,60
P/E ratio 2018 8,25
EV / Sales 2017 0,24x
EV / Sales 2018 0,21x
Capitalization 702 M
Chart AGFA-GEVAERT
Duration : Period :
Agfa-Gevaert Technical Analysis Chart | AGFB | BE0003755692 | 4-Traders
Technical analysis trends AGFA-GEVAERT
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 4,20 €
Spread / Average Target 2,9%
EPS Revisions
Managers
NameTitle
Christian Reinaudo President, Chief Executive Officer & Director
Julien de Wilde Chairman
Kris Hoornaert Chief Financial Officer
Jozef Cornu Non-Executive Director
Willy W. Duron Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
AGFA-GEVAERT11.16%828
THERMO FISHER SCIENTIFIC INC.34.10%75 478
DANAHER10.55%59 778
BOSTON SCIENTIFIC CORPORATION36.48%40 505
INTUITIVE SURGICAL67.64%39 496
ROYAL PHILIPS20.07%38 649